- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Pfizer Ratings Report.
The U.S. opioid crisis rages on. TheStreet takes a look at several drugs being used to help treat people.
Patent lawyers are intrigued and competitors will likely challenge, but the move to transfer ownership of the patent to the Saint Regis Mohawk tribe could cause other companies to try a similar tack.
Here's what you need to know now for Thursday, Sept. 14.
The Dow rises but the rest of the market falters Thursday. Here's where stocks are trading at market close.
There's one going on now.